Solgenics Limited - Director/PDMR Shareholding
News Release
PDMR Dealing
Articles of Association
Under Article 32 of the Company's Articles of Association, where a person or persons acting in concert acquire 30% or more of the Company's issued share capital, the Board may, but is not obliged to require such persons to extend the offer to all shareholders.
Further to the announcement on
This limit will be reassessed in light of the then current circumstances in the event that any of Seritza Limited,
Enquiries
For further information please visit www.solgenics.com or contact:
|
Solgenics: |
|
+27 (0) 71 362 3566 |
|
Liberum Capital Limited:
|
|
+44 (0) 20 3100 2000 |
|
Novum Securities Limited Joint Broker |
|
+44 (0) 20 7399 9427 |
|
Pimlico Advisory Ltd Investor Relations |
|
+44 (0) 777 56 55 927 |
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 which is part of
About Solgenics
Solgenics is an African renewable energy development company focused on the development of a 300MW solar PV plus BESS renewable energy in the
It is the intention that the Tete Solar Project will connect to the
The Tete Solar Project takes full advantage of
On
The notification below is made in accordance with the requirements of the MAR.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
|
1 |
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
|
a) |
Name |
|
||||
|
2 |
Reason for the notification
|
|||||
|
a) |
Position/status
|
Non-Executive Director |
||||
|
b)
|
Initial notification /Amendment |
Initial notification
|
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
|
a) |
Name |
Solgenics Limited
|
||||
|
b) |
LEI |
2138003W7PP9STE9J18
|
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of no par value
VGG640631039 |
||||
|
b) |
Nature of the transaction |
On-market purchase of Ordinary Shares
|
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
3,500,000
|
||||
|
e) |
Date of the transaction |
|
||||
|
f) |
Place of the transaction |
London Stock Exchange, AIM
|
||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE